Investcorp invests in China's leading SaaS and supply chain management provider for the dental and medical aesthetics industry - Linkedcare

Together with the Series C2 round of funding announced a few months ago, Linkedcare has now raised over $100 million during the past six months.

  
Investcorp invests in China's leading SaaS and supply chain management provider for the dental and medical aesthetics industry - Linkedcare

Beijing: Investcorp, a leading global provider and manager of alternative investment products, today announced that it has signed definitive agreements to invest in Linkedcare, China’s preeminent Software-as-a-Service (SaaS) and supply chain management provider for the country’s fast-growing dental and medical aesthetics industry.

This latest Series D round of funding was led by Investcorp with co-investors Matrix Partners China, Lightspeed China Partners, So-Young International, Jinding Capital and Sheng Ye Capital. Together with the Series C2 round of funding announced a few months ago, Linkedcare has now raised over $100 million during the past six months.

Founded in 2015 in Shanghai and with over 700 employees, Linkedcare currently serves more than 30,000 dental and medical aesthetic clinics in the mid-to-high-end segment with complete SaaS solutions covering standalone and chain management, outpatient and inpatient CRM, electronic medical records, inventory and sales management, financial reporting, insurance payment, imaging PACS, YouKe SCRM smart marketing, and YouShu smart business analytics, etc.

Mr. Hazem Ben-Gacem, Co-CEO of Investcorp, said: “We are pleased to lead this new round of investment into Linkedcare. China is experiencing strong demand in the dental, beauty and other consumer medical areas underpinned by secular growth in its economy and demographics and we look forward to being part of their growth trajectory. As part of our investment strategy, we have been actively growing our presence in Asia over the past years and this is yet another milestone that we have reached as we continue to advance our diversification journey.”

Mr. Zhijia Wu, CEO and Co-Founder of Linkedcare, said: “We are very pleased to welcome Investcorp as a new institutional investor into our blue-chip shareholder group. We look forward to developing highly synergetic cooperation with Investcorp’s portfolio companies in the global dental care industry to bring world-leading innovative products to our clinician customers in China.”

Mr. Duncan Zheng, MD & Head of Private Equity China at Investcorp, who will join the Board of Directors at Linkedcare, commented: “Linkedcare is a phenomenal innovator in China’s dental SaaS industry and we are very honored to partner with Mr. Wu and his excellent management team to further strengthen the Company’s leadership position through capital and value-added access to our global resources and sector expertise. We see many attractive investment opportunities in the Chinese healthcare sector as demand for quality medical services and treatments continue to increase. We believe that such opportunities will deliver enhanced value for all of our stakeholders.”

Last year, Investcorp launched a new platform dedicated to investing in high-quality healthcare companies in China. Linkedcare marks Investcorp’s fourth investment in China’s fast growing healthcare sector over the last 12 months, including: KindStar, China’s leading independent medical esoteric testing group; Lu DaoPei, the world’s leading blood oncology hospital group; and WeDoctor, one of China’s largest digital health services platforms.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.


More From Press Releases